19.06.2018 | Letter to the Editor
Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor
Erschienen in: Annals of Hematology | Ausgabe 1/2019
Einloggen, um Zugang zu erhalten